Dashboard
Manage Tickers

CNBX CNBX Pharmaceuticals Inc.

OTC cnbxpharma.com


$ 0.00 (0 %)    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 598.96 $ -2.23 (-0.37 %)
DIA $ 459.11 $ -3.15 (-0.68 %)
SPY $ 659.61 $ -4.53 (-0.68 %)
TLT $ 91.38 $ 0.68 (0.75 %)
GLD $ 399.00 $ 9.06 (2.34 %)
$ 0.00045
-- x --
-- x --
-- - --
$ 0.00 - $ 0.02
3,648,508
na
2,098
$ -22.42
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 07-14-2025 05-31-2025 10-Q
2 04-14-2025 02-28-2025 10-Q
3 01-13-2025 11-30-2024 10-Q
4 11-29-2024 08-31-2024 10-K
5 07-15-2024 05-31-2024 10-Q
6 04-16-2024 02-29-2024 10-Q
7 01-12-2024 11-30-2023 10-Q
8 11-30-2023 08-31-2023 10-K
9 07-14-2023 05-31-2023 10-Q
10 04-14-2023 02-28-2023 10-Q
11 01-13-2023 11-30-2022 10-Q
12 11-30-2022 08-31-2022 10-K
13 07-14-2022 05-31-2022 10-Q
14 04-12-2022 02-28-2022 10-Q
15 01-13-2022 11-30-2021 10-Q
16 11-29-2021 08-31-2021 10-K
17 07-14-2021 05-31-2021 10-Q
18 04-14-2021 02-28-2021 10-Q
19 01-14-2021 11-30-2020 10-Q
20 11-04-2020 08-31-2020 10-K
21 07-14-2020 05-31-2020 10-Q
22 04-13-2020 02-29-2020 10-Q
23 01-14-2020 11-30-2019 10-Q
24 11-29-2019 08-31-2019 10-K
25 07-15-2019 05-31-2019 10-Q
26 04-15-2019 02-28-2019 10-Q
27 01-17-2019 11-30-2018 10-Q
28 11-29-2018 08-31-2018 10-K
29 07-16-2018 05-31-2018 10-Q
30 04-05-2018 02-28-2018 10-Q
31 01-16-2018 11-30-2017 10-Q
32 12-08-2017 08-31-2017 10-K
33 07-17-2017 05-31-2017 10-Q
34 04-14-2017 02-28-2017 10-Q
35 01-17-2017 11-30-2016 10-Q
36 12-13-2016 08-31-2016 10-K
37 07-13-2016 05-31-2016 10-Q
38 04-18-2016 02-29-2016 10-Q
39 01-22-2016 11-30-2015 10-Q
40 01-07-2016 08-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION